AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
2.820
+0.050 (1.81%)
At close: May 19, 2026, 4:00 PM EDT
2.774
-0.046 (-1.63%)
After-hours: May 19, 2026, 5:44 PM EDT
AC Immune Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, AC Immune stock has a consensus rating of "Strong Buy" and an average price target of $8.93. The average 1-year stock price forecast is 216.67% higher than the current stock price, while the lowest is $6.98 (+147.52%) and the highest is $11.88 (+321.28%).
Price Target: $8.93 (+216.67%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for AC Immune stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +183.69% | May 4, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +183.69% | Mar 16, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +183.69% | Nov 4, 2025 |
| BTIG | BTIG | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +183.69% | Sep 8, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $16 → $12 | Strong Buy | Maintains | $16 → $12 | +325.53% | May 1, 2025 |
Financial Forecast
Revenue This Year
40.75M
from 3.57M
Increased by 1,040.39%
Revenue Next Year
97.35M
from 40.75M
Increased by 138.91%
EPS This Year
-0.53
from -0.70
EPS Next Year
0.25
from -0.53
Financial currency is CHF. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 95.7M | 202.1M | |||
| Avg | 40.7M | 97.3M | |||
| Low | 3.2M | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 2,577.2% | 396.1% | |||
| Avg | 1,040.4% | 138.9% | |||
| Low | -11.1% | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -0.37 | 1.42 | |||
| Avg | -0.53 | 0.25 | |||
| Low | -0.67 | -0.74 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.